NYR 19.0% 6.9¢ nyrada inc.

Ann: Brain Injury Program GLP Studies Further Update No 3, page-2

  1. 172 Posts.
    lightbulb Created with Sketch. 14
    Now that they have cleared the human genome and both the Rat central nervous system and now the respiratory system the drug has been heavily derisked leading into the final 3 test results before first human dosing
    Last edited by Bendunstan: 20/08/24
 
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.